首页> 美国卫生研究院文献>Aging (Albany NY) >NEAT1 regulates microtubule stabilization via FZD3/GSK3β/P-tau pathway in SH-SY5Y cells and APP/PS1 mice
【2h】

NEAT1 regulates microtubule stabilization via FZD3/GSK3β/P-tau pathway in SH-SY5Y cells and APP/PS1 mice

机译:Neat1通过SH-SY5Y细胞和APP / PS1小鼠的FZD3 /GSK3β/ P-Tau途径调节微管稳定性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nuclear paraspeckles assembly transcript 1 (NEAT1) is a well-known long noncoding RNA (lncRNA) with various functions in different physiological and pathological processes. Notably, aberrant NEAT1 expression is implicated in the pathogenesis of various neurodegenerative diseases, including Alzheimer’s disease (AD). However, the molecular mechanism of NEAT1 in AD remains poorly understood. In this study, we investigated that NEAT1 regulated microtubules (MTs) polymerization via FZD3/GSK3β/p-tau pathway. Downregulation of NEAT1 inhibited Frizzled Class Receptor 3 (FZD3) transcription activity by suppressing H3K27 acetylation (H3K27Ac) at the FZD3 promoter. Our data also demonstrated that P300, an important histone acetyltransferases (HAT), recruited by NEAT1 to bind to FZD3 promoter and mediated its transcription via regulating histone acetylation. In addition, according to immunofluorescence staining of MTs, metformin, a medicine for the treatment of diabetes mellitus, rescued the reduced length of neurites detected in NEAT1 silencing cells. We suspected that metformin may play a neuroprotective role in early AD by increasing NEAT1 expression and through FZD3/GSK3β/p-tau pathway. Collectively, NEAT1 regulates microtubule stabilization via FZD3/GSK3β/P-tau pathway and influences FZD3 transcription activity in the epigenetic way.
机译:核ParaSpecles组装转录物1(neat1)是一种具有众所周知的长非编码RNA(LNCRNA),其具有不同生理和病理过程的各种功能。值得注意的是,异常Neat1表达涉及各种神经变性疾病的发病机制,包括阿尔茨海默病(AD)。然而,AD中的Neat1的分子机制仍然明显差不多。在该研究中,我们研究了通过FZD3 /GSK3β/ P-Tau途径的Neat1调节的微管(MTS)聚合。通过在FZD3启动子下抑制H3K27乙酰化(H3K27AC),Neat1的下调抑制了FrizeD类受体3(FZD3)转录活性。我们的数据还证明P300是由Neat1募集的重要组氨酸乙酰转移酶(帽子)与FZD3启动子结合并通过调节组蛋白乙酰化介导其转录。此外,根据MTS,二甲双胍的免疫荧光染色,一种用于治疗糖尿病的药物,抢救了Neat1沉默细胞中检测到的神经脉的减少。我们怀疑二甲双胍可以通过增加Neat1表达和通过FZD3 /GSK3β/ P-Tau途径在早期广告中发挥神经保护作用。总的来说,Neat1通过FZD3 / GSK3 / P-Tau途径调节微管稳定,并影响表观遗传方式中的FZD3转录活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号